PMID: 9545707Apr 18, 1998Paper

Outcome of intensive care

Medizinische Klinik
H P Schuster

Abstract

The mean hospital mortality of patients after intensive therapy in Germany is about 15%, the mortality within the intensive care unit about 8%. Short-term prognosis is mainly determined by severity of disease, type of disease and patient age. The impact of disease severity is measured by acute physiology score systems. The significance of disease categories becomes apparent in disease states with a continuing high mortality. Age is an independent risk factor. The higher risk of older patients cannot be explained by different diagnosis, and it is not secondary to a less aggressive therapy. The same factors mainly determine long-term prognosis. The 5-year-survival rate after intensive therapy is around 60%, a 3-fold increase as compared to the general population. Dependent upon the disease category, survival curves of intensive care patients parallel survival curves of the general population 2 years after admission. Analysis of quality of life is based upon objective measurement and subjective estimation of health-related life quality in the physical, psychological, and social life domain. Patients after intensive therapy experience a moderate but significant decrease in quality of life. This is the case in global estimations of ...Continue Reading

References

Dec 1, 1992·Critical Care Medicine·J E KassF Malakoff
Sep 1, 1992·Critical Care Medicine·G Vazquez MataE Aguayo de Hoyos
Nov 1, 1989·Critical Care Medicine·M FulopG Levin
Sep 1, 1986·Critical Care Medicine·R L GoldsteinE Skinner
Jan 1, 1988·Intensive Care Medicine·C J JacobsC J van der Linden
Apr 1, 1987·Journal of the American Geriatrics Society·W M SageW M Bortz
Aug 1, 1987·Critical Care Medicine·B Zarén, U Hedstrand
Sep 1, 1986·Critical Care Medicine·W M SageJ F Silverman
Nov 1, 1986·Journal of General Internal Medicine·T J StarrR F Uhlmann
Nov 1, 1984·Critical Care Medicine·J R Le GallD Villers
May 1, 1995·Intensive Care Medicine·Z M Tian, D R Miranda
Jan 1, 1994·Intensive Care Medicine·P BurtinA Larcan
Sep 1, 1993·Australian Journal of Public Health·S SchwartzP P Glasziou
May 1, 1993·Critical Care Medicine·K RockwoodM Grace
Mar 28, 1996·The New England Journal of Medicine·M A Testa, D C Simonson
Sep 1, 1996·Intensive Care Medicine·M CapuzzoG Gritti
Dec 1, 1996·Intensive Care Medicine·X BadiaD L Patrick
May 1, 1997·Intensive Care Medicine·R BrooksK Daffurn

❮ Previous
Next ❯

Citations

Oct 29, 1998·Medizinische Klinik·A von BierbrauerP von Wichert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.